CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology ...
The global MRI systems market is witnessing robust growth, propelled by technological advancements, rising chronic disease prevalence, and demand for non-invasive diagnostics. High-field MRI and AI ...
The anticipated acquisition aligns with GE HealthCare’s precision care strategy with the goal of strengthening the company’s portfolio of offerings in neurological care and its quantitative analysis ...
GE HealthCare has entered an agreement to acquire AI-based brain imaging company icometrix to expand its magnetic resonance (MR) imaging capabilities for neurological disorders. The imaging giant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results